A 10-year follow up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse population.

Vanderbilt research indicates that adding liquid biopsy testing for circulating tumor DNA mutations increases targetable mutation detection rates.

Vanderbilt biostatisticians have developed an immunotherapy response model that outperforms existing predictive models.

Chic Awearness is now supporting two new ovarian cancer research initiatives at Vanderbilt University Medical Center and providing matching funding for a social worker to coordinate Woman to Woman, a peer mentoring program launched at VUMC in 2023.

Vanderbilt researchers are studying a potential therapy for acute myeloid leukemia that targets the residual leukemic stem cells in bone marrow after treatment that are responsible for relapses and drug resistance.

Collegiate tennis and golf athletes aren’t using enough sunscreen according to a recent survey; meanwhile, the deadly skin cancer melanoma is on the rise.